🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I, open-label, 2-part study in patients with a confirmed di...
Status
Completed
Location
Research Site
Start Date
2014-12-22
Trial ID
NCT02197234
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Recruiting
Location
Usc Norris Comprehensive Cancer Center (Nccc)
Start Date
2024-12-09
Trial ID
NCT06625593
Treatments Being Tested
This phase 2 trial is a single-site sequential, multiple assignment, random...
Status
Recruiting
Location
Corewell Health West
Start Date
2026-06
Trial ID
NCT07459504
Treatments Being Tested
This study is the first administration of GSK2982772 in humans. The study w...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-01-06
Trial ID
NCT02302404
Treatments Being Tested
Aim: This experimental study aims to investigate the impact of an Artificia...
Status
Not Yet Recruiting
Location
Selcuk University
Start Date
2026-04-30
Trial ID
NCT07564544
Treatments Being Tested
This clinical trial is studying different methods of preparing bone for den...
Status
Completed
Location
Istanbul Aydın University, Faculty of Dentistry
Start Date
2019-09-01
Trial ID
NCT07234214
People with sepsis who are treated in the intensive care unit (ICU) often h...
Status
Not Yet Recruiting
Location
Emergebcy Clinical County Hospital - Intensive Care Clinic
Start Date
2026-02-02
Trial ID
NCT07391098
Treatments Being Tested
Patients with chronic hepatitis B and treated with entecavir for over 6 mon...
Status
Completed
Location
The University of Hong Kong
Start Date
2007-06
Trial ID
NCT01013272
Treatments Being Tested
Physiotherapy is a key treatment for patients with bronchiectasis. An evalu...
Status
Recruiting
Location
Respiratory and Critical Care Unit, IRCCS Azienda Ospedaliera-Universitaria di Bologna
Start Date
2024-12-01
Trial ID
NCT06801327
Treatments Being Tested
RATIONALE: Bortezomib and thalidomide may stop the growth of multiple myelo...
Status
Completed
Location
City of Hope Medical Center
Start Date
2008-01-16
Trial ID
NCT00792142